Healthcare AI advisor in Latin America
In short
Roberto Echeverría Cárdenas is a healthcare AI advisor based in San José, Costa Rica. He helps the leadership of hospitals, clinics and health companies in Costa Rica and Mexico decide which AI tools deserve their trust, how to implement them and how to measure whether they work. He reviews the published evidence for each tool before recommending it: that is how he built the map of healthcare AI agents in Latin America, with 62 companies, and the review of which ones have published studies. He is a founding partner of Cumbre Advisors with Esteban Morales, founder and CEO of Flow Results, and institutional co-author of Sextante.
A public example: what evidence the region's healthcare AI agents have
On 1 October 2026, Scalekit published a map of who is building AI agents for healthcare in the United States. There was none for Latin America, so I built it. On 9 October I published the map of healthcare AI agents in Latin America: 62 companies in six categories, from clinical documentation to revenue cycle, each with a public source.
A reader asked whether the 41 names on the one-page version had outcome studies. I looked them up one by one. This is what I found:
- 62
- companies in six categories, each with a public source
- 41
- names on the one-page version, checked one by one
- ~10
- with a published study that describes its method
- 1
- patient outcome, and it is a conference abstract
Almost all of those studies measure accuracy, process or use, and most are signed by the company or by the hospital that built the tool. Only for TeleDx and NoHarm.ai did I find evaluations signed by third parties. On 12 October I corrected the map with what I found and noted it on the same page.
The English version reached 22,960 impressions on LinkedIn in its first three days, with 166 reactions and 110 saves; almost a third of the people who saw it work in hospitals and healthcare. Before that, on 5 October, I published the map of Latin American health startups (in Spanish), with 299 companies in 19 countries and 392 founders, updated every month.
That is the question a leadership team brings when a vendor offers a tool: what evidence exists, who signed it and what is still unmeasured. It is worth answering before the contract is signed. The seven questions are in this guide for hospital directors (in Spanish).
The questions leadership teams bring
Which AI tool deserves our trust?
Before buying, we review what documented use and what published studies the tool has, who signed them, what they measured and what is still unmeasured. It is the same method as the map of healthcare AI agents in Latin America, applied to the options on the table.
Which AI project should we start with?
We define the problem, who owns it inside the organization and how it will be evaluated before choosing a tool.
How will we know it works?
Before implementation we agree on what will be measured, against which baseline, who reports it and on what date the organization decides whether the tool stays. Without that, a pilot proves nothing.
How do we prepare the leadership team?
With hands-on training built on the organization's own cases, so decisions do not depend on a single vendor or a single person.
What do AI assistants say today when a patient asks about our hospital?
We review what ChatGPT, Gemini and Perplexity say about the organization, which sources they use and what is missing or out of date. When patients ask an assistant first, the public information the organization needs changes, and so does the way results are measured.
How the work is organized
Cumbre Advisors
The firm Esteban Morales and I founded. There we work together on advisory and institutional implementation: priorities, owners and AI projects for each health organization. Visit Cumbre Advisors.
Flow Results
The agency I founded and lead. It focuses on medical marketing, clinic growth and visibility in AI assistants for doctors and clinics in Costa Rica and Mexico.
Sextante
Independent research of which I am institutional co-author, under the technical direction of Sebastián Urbina Cañas. It studies how AI assistants represent hospitals. It does not assess medical quality and is not a service. Read the method (Spanish).
Limits and interests
I am not a physician. I review the evidence that exists about a tool and help leadership decide with it; clinical judgment about each patient and the clinical validation of an algorithm belong to clinical teams and regulators. I do not recommend doctors or assess a hospital's clinical quality.
Disclosure of interests. Flow Results, my agency, provides marketing services to doctors and clinics and sells AI agents to doctors (Agente Flow). I am an advisor to Konko AI. I co-founded Costa Rica's Medical Marketing Congress with Huli and have spoken at its events.
Where to verify it
External sources that describe this work. The full list, with dates and context, is on Media and interviews (in Spanish).
- Bloomberg Línea, 4 October 2026 (Spanish)
Reports the Sextante results and cites him as co-author of the study.
- IT NOW, 29 September 2026 (Spanish)
Identifies him as co-author of Sextante and a consultant on AI applied to health.
- El Sol de Tampico, 24 September 2026 (Spanish)
Quotes him as a healthcare AI advisor and founder of Flow Results.
- La Gaceta No. 141, 21 July 2011 (Spanish)
Records his post as Advisor to the Minister's Office at Costa Rica's Ministry of Health.
Frequently asked questions
Who is Roberto Echeverría Cárdenas?
Roberto Echeverría Cárdenas is a healthcare AI advisor based in San José, Costa Rica. He helps the leadership of hospitals, clinics and health companies in Costa Rica and Mexico decide which AI tools deserve their trust, how to implement them and how to measure whether they work. He reviews the published evidence for each tool before recommending it: that is how he built the map of healthcare AI agents in Latin America, with 62 companies, and the review of which ones have published studies. He is a founding partner of Cumbre Advisors with Esteban Morales, founder and CEO of Flow Results, and institutional co-author of Sextante.
What does a healthcare AI advisor do?
Helps the leadership of a hospital, clinic or health company decide what to do with artificial intelligence: which tools deserve trust given the evidence they have, which project to start with, who owns it and how to measure whether it works. It does not replace clinical judgment or the organization's technical team.
Does Roberto Echeverría Cárdenas evaluate clinical AI tools?
Yes, by their evidence. He reviews what documented use and what published studies each tool has, who signed them and what they measured, and uses that to help leadership decide whether to adopt it, how to implement it and how to measure whether it works. With that method he published the map of healthcare AI agents in Latin America in October 2026: of the 41 names on its one-page version, about ten have a study with a described method, and there is a single patient outcome, a conference abstract. He is not a physician: clinical judgment about each patient and the clinical validation of an algorithm belong to clinical teams and regulators.
What is the map of healthcare AI agents in Latin America?
An open list of 62 companies and internal teams building AI agents for healthcare in the region, in six categories, with one public source per name and a count of which have documented use. Roberto Echeverría Cárdenas published it on 9 October 2026, in Spanish and English, and corrected it on 12 October after reviewing the outcome studies for each name. A monthly map of Latin American health startups, with 299 companies in 19 countries, goes with it.
Which countries does he work in?
He is based in San José, Costa Rica. He works with clinics, hospitals and health companies in Costa Rica and Mexico, and travels regularly to Mexico and other Latin American countries.
How does an engagement start?
Institutional advisory work is done through Cumbre Advisors, the firm founded by Esteban Morales and Roberto Echeverría Cárdenas. For a first conversation, write through the contact page or book a consulting hour.
How is the advisory work related to Sextante?
There is no commercial relationship. Sextante is independent research on how AI assistants represent hospitals, under the technical direction of Sebastián Urbina Cañas. It does not assess medical quality and is not a sales step for Cumbre or Flow.
Let's talk
Tell me what is changing in your organization, who is handling it today and what you need to decide. I reply in English or Spanish.
Published on 17 October 2026.